Skip to content

Clinical trials

Huntington Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Country / region: Netherlands Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20121
20131
20142
20153
20191
20201
20212
20221
20232
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Prilenia4
CHDI Foundation, Inc.3
Novartis Pharmaceuticals3
Leiden University Medical Center2
European Huntington's Disease Network1
GlaxoSmithKline1
Hoffmann-La Roche1
Institut National de la Santé Et de la Recherche Médicale, France1
Teva Branded Pharmaceutical Products R&D, Inc.1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease20
Neurodegenerative Diseases2
Rare Diseases2
Machado-Joseph Disease1
Nerve Degeneration1
Neuroinflammatory Diseases1
Pain1
Spinocerebellar Ataxias1
Spinocerebellar Degenerations1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.